Susquehanna International Group, LLP Moderna, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	SELL	$101.21 - $166.61 $35 Million - $57.6 Million	-345,500 Reduced 12.76%	2,362,800 $281 Million
Q1 2024 May 07, 2024	SELL	$85.37 - $115.44 $53.3 Million - $72.1 Million	-624,800 Reduced 18.75%	2,708,300 $289 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $7.88 Million - $11.8 Million	113,300 Added 3.52%	3,333,100 $331 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $104 Million - $136 Million	1,077,400 Added 50.29%	3,219,800 $333 Million
Q2 2023 Aug 11, 2023	SELL	$118.5 - $160.53 $40.5 Million - $54.8 Million	-341,600 Reduced 13.75%	2,142,400 $260 Million
Q1 2023 May 16, 2023	SELL	$135.66 - $197.02 $209 Million - $303 Million	-1,539,800 Reduced 38.27%	2,484,000 $381 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $260 Million - $461 Million	2,196,200 Added 120.17%	4,023,800 $723 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $78.9 Million - $130 Million	-668,400 Reduced 26.78%	1,827,600 $216 Million
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $195 Million - $294 Million	-1,663,200 Reduced 39.99%	2,496,000 $357 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $149 Million - $277 Million	-1,180,500 Reduced 22.11%	4,159,200 $716 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $271 Million - $442 Million	-1,200,300 Reduced 18.35%	5,339,700 $1.36 Billion
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $92.4 Million - $202 Million	416,300 Added 6.8%	6,540,000 $2.52 Billion
Q2 2021 Aug 11, 2021	BUY	$129.91 - $234.98 $77,946 - $140,988	600 Added 0.01%	6,123,700 $1.44 Billion
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $58.7 Million - $100 Million	-538,000 Reduced 8.08%	6,123,100 $802 Million
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $219 Million - $567 Million	3,336,100 Added 100.33%	6,661,100 $696 Million
Q3 2020 Nov 16, 2020	BUY	$54.34 - $94.85 $39.9 Million - $69.7 Million	735,100 Added 28.38%	3,325,000 $235 Million
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $37 Million - $99.8 Million	1,246,900 Added 92.84%	2,589,900 $166 Million
Q1 2020 May 15, 2020	BUY	$17.78 - $31.58 $20.4 Million - $36.3 Million	1,149,600 Added 594.42%	1,343,000 $40.2 Million
Q4 2019 Feb 14, 2020	SELL	$13.93 - $21.28 $764,757 - $1.17 Million	-54,900 Reduced 22.11%	193,400 $3.78 Million
Q3 2019 Nov 14, 2019	BUY	$12.26 - $18.07 $852,070 - $1.26 Million	69,500 Added 38.87%	248,300 $3.95 Million
Q2 2019 Aug 14, 2019	SELL	$13.7 - $28.34 $249,340 - $515,788	-18,200 Reduced 9.24%	178,800 $2.62 Million
Q1 2019 May 15, 2019	BUY	$14.45 - $23.7 $2.85 Million - $4.67 Million	197,000 New	197,000 $4.01 Million

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account